Home MS CureMS Treatments Rituximab Treatment for Multiple Sclerosis

Rituximab Treatment for Multiple Sclerosis

by admin

The YouTube ID of RpE6BgK4k3I is invalid.
 
Very detailed presentation using Rituximab in the treatment for Multiple Sclerosis at Neurology Grand Rounds on 15th of July 2015. Rituximab is widely used off-label to treat difficult cases of multiple sclerosis, systemic lupus erythematosus, chronic inflammatory demyelinating polyneuropathy and autoimmune anemias.

Patents on the drug in expired in Europe in February 2013 and in the US in September 2016. By February 2017 several biosimilars had been approved in India and one biosimilar had received approval in Europe.

Related Posts

We use cookies to personalize content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services Accept Read More